ArticleMolecular cancer research : MCR2021

Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling.

Amy R Dwyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.